Status:
COMPLETED
Immunological Consequences of CARD15/NOD2 Mutations in Crohn's Disease
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Crohn's Disease
Eligibility:
All Genders
5-65 years
Phase:
NA
Brief Summary
The project is based on adult and paediatric cohorts among the largest ones in Paris and located at Saint Louis and Robert Debré hospitals. Experiments will be performed at INSERM Unit U843 in collabo...
Detailed Description
Crohn's Disease (CD) affects about 60.000 to 80.000 people in France. It is characterised by a chronic or relapsing inflammation of the gut. Its aetiology is largely unknown, limiting the development ...
Eligibility Criteria
Inclusion
- Children and adults ≥ 5 ans and ≤ 65 ans with a programmed routine colonoscopy for Crohn's disease, ulcerative colitis, or another benign gastroenterological disorder
Exclusion
- Patients \< 5 ans or \> 65 ans
- Patients with contra-indications for multiple biopsies
- Patients with an undeterminate colitis
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00780949
Start Date
January 1 2009
End Date
January 1 2012
Last Update
August 3 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Robert Debre
Paris, France, 75019